Renalytix Plc (AIM:RENX)

Kronos Bio Revenue

Renalytix had revenue of $1.25M USD in the quarter ending December 31, 2024, with 76.45% growth. This brings the company's revenue in the last twelve months to $2.89M, up 20.08% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.

• Revenue (ttm): $2.89M
• Revenue Growth: +20.08%
• P/S Ratio: 10.75
• Revenue / Employee: $28.37K
• Employees: 102
• Market Cap: 24.84M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	2.29M	-1.11M	-32.74%
Jun 30, 2023	3.40M	433.00K	14.58%
Jun 30, 2022	2.97M	1.48M	99.20%
Jun 30, 2021	1.49M	-	-
Jun 30, 2020	-	-	-